Our pipeline is built on the proven strength of aminopyridines—ion-channel modulators with a long history of safety and therapeutic benefit. By refining and advancing this well-understood class, we’re developing treatments designed to protect and restore nerve function where existing options fall short.

Our programs target some of the most challenging neurological conditions, including hereditary ataxias, traumatic nerve injury, and chemotherapy-induced neuropathy, with the goal of improving mobility, coordination, and quality of life for patients who urgently need better solutions.